NASDAQ:WALD Waldencast (WALD) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free WALD Stock Alerts $5.21 0.00 (0.00%) (As of 03:44 PM ET) Add Compare Share Share Today's Range$5.18▼$5.4050-Day Range$5.21▼$7.5952-Week Range$5.00▼$12.00Volume13,722 shsAverage Volume69,911 shsMarket Capitalization$560.44 millionP/E RatioN/ADividend YieldN/APrice Target$10.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get Waldencast alerts: Email Address Waldencast MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside91.9% Upside$10.00 Price TargetShort InterestBearish5.87% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.34Based on 4 Articles This WeekInsider TradingN/AProj. Earnings Growth316.67%From $0.06 to $0.25 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.92 out of 5 starsConsumer Staples Sector104th out of 132 stocksToilet Preparations Industry11th out of 12 stocks 3.3 Analyst's Opinion Consensus RatingWaldencast has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageWaldencast has only been the subject of 1 research reports in the past 90 days. Previous Next 0.0 Short Interest Percentage of Shares Shorted5.87% of the float of Waldencast has been sold short.Short Interest Ratio / Days to CoverWaldencast has a short interest ratio ("days to cover") of 11.4, which indicates bearish sentiment.Change versus previous monthShort interest in Waldencast has recently increased by 17.21%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldWaldencast does not currently pay a dividend.Dividend GrowthWaldencast does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for WALD. Previous Next 1.9 News and Social Media Coverage News SentimentWaldencast has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Waldencast this week, compared to 1 article on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Waldencast insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.90% of the stock of Waldencast is held by insiders.Percentage Held by Institutions41.97% of the stock of Waldencast is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Waldencast are expected to grow by 316.67% in the coming year, from $0.06 to $0.25 per share.Price to Book Value per Share RatioWaldencast has a P/B Ratio of 0.70. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Waldencast Stock (NASDAQ:WALD)Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners. The company is headquartered in White Plains, New York.Read More WALD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart WALD Stock News HeadlinesApril 21, 2024 | prnewswire.comROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDWApril 16, 2024 | markets.businessinsider.comROSEN, A TOP RANKED LAW FIRM, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDWApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.April 15, 2024 | prnewswire.comTOP RANKED ROSEN LAW FIRM Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDWApril 7, 2024 | msn.comStocks Settle Higher as a Strong US Labor Market Powers the EconomyMarch 30, 2024 | markets.businessinsider.comROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDWMarch 25, 2024 | globenewswire.comWaldencast Regains Compliance with Nasdaq Filing RequirementsMarch 24, 2024 | prnewswire.comROSEN, NATIONAL TRIAL LAWYERS, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDWApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.March 21, 2024 | stockhouse.comJohnson Fistel, LLP is Investigating Waldencast for Violation of Securities Laws; WALD, WALDWMarch 21, 2024 | finanznachrichten.deWaldencast plc.: Waldencast Reports First Half 2023 ResultsMarch 20, 2024 | globenewswire.comWaldencast Reports First Half 2023 ResultsMarch 17, 2024 | prnewswire.comROSEN, LEADING INVESTOR COUNSEL, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDWMarch 14, 2024 | finance.yahoo.comBATH & BODY WORKS AND NETFLIX JOIN FORCES TO BRING FRAGRANCE AND BELOVED STORIES TO LIFE FOR CONSUMERS AND FANSMarch 11, 2024 | markets.businessinsider.comTOP RANKED ROSEN LAW FIRM Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDWMarch 11, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsOn Behalf of Investors of Waldencast plc - WALDMarch 11, 2024 | finance.yahoo.comTGT Mar 2024 130.000 putMarch 8, 2024 | prnewswire.comROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDWMarch 7, 2024 | globenewswire.comObagi Cosmeceuticals Announces the Launch of Daily Hydro-Drops® Rejuvenating Eye Gel CreamMarch 3, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALDFebruary 28, 2024 | stockhouse.comWaldencast's (WALD) CFO/COO Gautier Abruptly Exits Amid SEC's Investigation into Company's Improper Accounting - Hagens BermanFebruary 26, 2024 | globenewswire.comWaldencast Receives Positive Nasdaq Listing DeterminationFebruary 26, 2024 | businesswire.comWaldencast plc (WALD, WALDW) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsFebruary 24, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALDFebruary 22, 2024 | globenewswire.comWaldencast Announces New “Creative Council” of Industry Pioneers and DisruptorsFebruary 20, 2024 | finance.yahoo.comDr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc.February 20, 2024 | globenewswire.comDr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc.See More Headlines Receive WALD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Waldencast and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Toilet preparations Sub-IndustryN/A Current SymbolNASDAQ:WALD CUSIPN/A CIK1840199 Webwww.waldencast.com Phone917-546-6828FaxN/AEmployees272Year FoundedN/APrice Target and Rating Average Stock Price Target$10.00 High Stock Price Target$10.00 Low Stock Price Target$10.00 Potential Upside/Downside+91.9%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$166.13 million Price / Sales3.37 Cash FlowN/A Price / Cash FlowN/A Book Value$7.44 per share Price / Book0.70Miscellaneous Outstanding Shares107,570,000Free Float101,219,000Market Cap$560.44 million OptionableNot Optionable Beta-0.53 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Felipe Dutra (Age 59)Executive Chairman Mr. Michel Brousset (Age 51)Founder, CEO, CFO, Principal Accounting Officer & Director Ms. Hind Sebti (Age 45)Founder & Chief Growth Officer Elisabeth MilanGeneral CounselKey CompetitorsYatsenNYSE:YSGOlaplexNASDAQ:OLPXEdgewell Personal CareNYSE:EPCOatly GroupNASDAQ:OTLYCresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y AgropecuariaNASDAQ:CRESYView All CompetitorsInstitutional OwnershipSimplicity Wealth LLCBought 21,853 shares on 4/24/2024Ownership: 0.020%Zeno Equity Partners LLPBought 780,000 shares on 4/22/2024Ownership: 14.254%Norden Group LLCBought 14,105 shares on 4/19/2024Ownership: 0.013%Zeno Equity Partners LLPBought 20,500,710 shares on 2/27/2024Ownership: 19.058%Truxt Investmentos Ltda.Bought 144,841 shares on 2/2/2024Ownership: 3.789%View All Institutional Transactions WALD Stock Analysis - Frequently Asked Questions Should I buy or sell Waldencast stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waldencast in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" WALD shares. View WALD analyst ratings or view top-rated stocks. What is Waldencast's stock price target for 2024? 2 brokers have issued twelve-month price targets for Waldencast's stock. Their WALD share price targets range from $10.00 to $10.00. On average, they predict the company's stock price to reach $10.00 in the next twelve months. This suggests a possible upside of 91.9% from the stock's current price. View analysts price targets for WALD or view top-rated stocks among Wall Street analysts. How have WALD shares performed in 2024? Waldencast's stock was trading at $10.94 at the beginning of the year. Since then, WALD shares have decreased by 52.4% and is now trading at $5.21. View the best growth stocks for 2024 here. Are investors shorting Waldencast? Waldencast saw a drop in short interest in March. As of March 31st, there was short interest totaling 697,400 shares, a drop of 16.9% from the March 15th total of 839,200 shares. Based on an average daily volume of 66,300 shares, the days-to-cover ratio is currently 10.5 days. Approximately 5.0% of the company's stock are sold short. View Waldencast's Short Interest. Who are Waldencast's major shareholders? Waldencast's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Zeno Equity Partners LLP (14.25%), Simplicity Wealth LLC (0.02%) and Norden Group LLC (0.01%). How do I buy shares of Waldencast? Shares of WALD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:WALD) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsTrump is sounding the alarmPreserve GoldJim Cramer’s “The Biggest Drug Ever”Behind the MarketsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Waldencast plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
